Health - World Health Organization issued new guidelines of antiretroviral therapy for people with HIV/AIDS. Developing countries are asked to speed up delivery of antiretroviral drugs so that the level of mortality and transmission of distress.
As stated in Clinical Research Meeting 2010, which organized the Association of Physicians AIDS Care Indonesia, Thursday (30 / 9).
Prof. Zubairi Djoerban of HIV Integrated Services Centre Cipto Mangunkusumo said the presence of antiretroviral drugs give hope. Progressive damage to the immune system by HIV infection can be prevented by initiating antiretroviral therapy early on, when people who are infected do not show any symptoms.
Antiretroviral Guidelines World Health Organization (WHO) encourages early diagnosis and begin treatment when the calculation result is less than 350 CD4 cells per mm. CD4 is a marker of immunity. Early therapy is also recommended for patients with tuberculosis, chronic hepatitis B infection, and pregnant women to reduce the risk of death. In previous guidelines, the provision of antiretrovirals at least starting CD4 count of less than 200 cells per mm.
Zubairi said that early therapy is better because of declining death rates. Providing antiretroviral drugs to reduce early deaths by 75 percent. "In fact, antiretroviral therapy can prevent the transmission of up to 92 percent. The incidence of tuberculosis also can be reduced to 50 percent, "he said.
He argues, Indonesia should strive to adopt the new guidelines, given the rapid rate of HIV / AIDS, although their implementation remains to consider the infrastructure and availability of the drug.
In the world, antiretroviral drug users reached 5.2 million people. In Indonesia alone approximately 25,000 people with HIV / AIDS have received the drug. "It is a crime if people with HIV / AIDS is not treated. Whoever it was time to get the drug, should be treated, "he said.
Chairman of the Indonesian Medical Association for AIDS Care Samsuridjal Djauzi said, since national antiretroviral program began in 2004, the death rate fell from 46 percent to 17 percent in two years. If people with HIV/AIDS can survive from an opportunistic infection, usually a good life expectancy.
As stated in Clinical Research Meeting 2010, which organized the Association of Physicians AIDS Care Indonesia, Thursday (30 / 9).
Prof. Zubairi Djoerban of HIV Integrated Services Centre Cipto Mangunkusumo said the presence of antiretroviral drugs give hope. Progressive damage to the immune system by HIV infection can be prevented by initiating antiretroviral therapy early on, when people who are infected do not show any symptoms.
Antiretroviral Guidelines World Health Organization (WHO) encourages early diagnosis and begin treatment when the calculation result is less than 350 CD4 cells per mm. CD4 is a marker of immunity. Early therapy is also recommended for patients with tuberculosis, chronic hepatitis B infection, and pregnant women to reduce the risk of death. In previous guidelines, the provision of antiretrovirals at least starting CD4 count of less than 200 cells per mm.
Zubairi said that early therapy is better because of declining death rates. Providing antiretroviral drugs to reduce early deaths by 75 percent. "In fact, antiretroviral therapy can prevent the transmission of up to 92 percent. The incidence of tuberculosis also can be reduced to 50 percent, "he said.
He argues, Indonesia should strive to adopt the new guidelines, given the rapid rate of HIV / AIDS, although their implementation remains to consider the infrastructure and availability of the drug.
In the world, antiretroviral drug users reached 5.2 million people. In Indonesia alone approximately 25,000 people with HIV / AIDS have received the drug. "It is a crime if people with HIV / AIDS is not treated. Whoever it was time to get the drug, should be treated, "he said.
Chairman of the Indonesian Medical Association for AIDS Care Samsuridjal Djauzi said, since national antiretroviral program began in 2004, the death rate fell from 46 percent to 17 percent in two years. If people with HIV/AIDS can survive from an opportunistic infection, usually a good life expectancy.
No comments:
Post a Comment